N,N-Dipropyldopamine (hydrobromide)

CAT:

804-HY-132219-04

Size:

1 mg

Price:

Ask

For price, please contact [email protected]

CAS Number: 65273-66-7
UNSPSC Description: N. N-dipropyrldopamine is a potent inhibitor of glutamate release and has anticancer activity. The increase of glutamate secretion leads to cancer-induced bone pain (CIBP). N. N-dipropyrldopamine plays an analgesic role in CIBP[1].
Target Antigen: Others
Type: Reference compound
Related Pathways: Others
Field of Research: Cancer
Assay Protocol: https://www.medchemexpress.com/n-n-dipropyldopamine-hydrobromide.html
Purity: 98.22
Solubility: 10 mM in DMSO
Smiles: OC1=CC=C(CCN(CCC)CCC)C=C1O.[H]Br
Molecular Weight: 318.25
References & Citations: [1]Fazzari J, et al. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain. Sci Rep. 2015 Feb 11;5:8380.
Shipping Conditions: Room Temperature
Storage Conditions: 4°C (Powder, sealed storage, away from moisture)
Clinical Information: No Development Reported

Cat	Name
HY-132219-01	N,N-Dipropyldopamine (hydrobromide)
HY-132219-04	N,N-Dipropyldopamine (hydrobromide)
HY-132219-03	N,N-Dipropyldopamine (hydrobromide)
HY-132219-02	N,N-Dipropyldopamine (hydrobromide)
HY-W408607	N-Benzylacetamidine (hydrobromide)
HY-W108867	N-Fmoc-ethylenediamine (hydrobromide)
HY-B2146	Scopolamine N-oxide hydrobromide
HY-W011556-01	N,N,N',N'-Tetramethylchloroformamidinium hexafluorophosphate
HY-135072-02	N,N',N''-Triacetylchitotriose
HY-W011556-02	N,N,N',N'-Tetramethylchloroformamidinium hexafluorophosphate

Cat	Name
T38221-50mg	N,N-Dipropyldopamine (hydrobromide)
T38221-10mg	N,N-Dipropyldopamine (hydrobromide)
T38221-1mg	N,N-Dipropyldopamine (hydrobromide)
T38221-5mg	N,N-Dipropyldopamine (hydrobromide)
T38221-1g	N,N-Dipropyldopamine (hydrobromide)
574083	N,N-Dipropyldopamine HBr
C3084-5	N-Benzylacetamidine (hydrobromide)
C3084-100	N-Benzylacetamidine (hydrobromide)
sc-295668A	N-Benzylacetamidine Hydrobromide
C3084-50	N-Benzylacetamidine (hydrobromide)